Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Globomax Service Group

Globomax Service Group
1997 FOUNDED
M&A STATUS
71-80 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of pharmaceutical product development and support services. The company's pharmaceutical services include product development, project management, product lifecycle management, quality and compliance, biopharmaceutics, biostatistics, clinical research and preclinical research services for pharmaceutical and biotech companies.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • 7250 Parkway Drive
  • Suite 430
  • Hanover, MD 21076
  • United States

Globomax Service Group Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Globomax Service Group‘s full profile, request access.

Request full access to PitchBook

Globomax Service Group Executive Team (3)

Name Title Board
Seat
Contact
Info
David Young Ph.D Co-Founder, President & Chief Executive Officer
Tom Delaney Chief Financial Officer
Keith Chan Ph.D Co-Founder, Senior Vice President & Vice President of Regulatory Affairs and Quality Assurance